SEXUAL FUNCTION AFTER HYPOFRACTIONATED VERSUS CONVENTIONALLY FRACTIONATED RADIOTHERAPY FOR PROSTATE CANCER: RESULTS OF THE PROSPECTIVE, RANDOMIZED PHASE 3 HYPRO TRIAL

被引：1
|
作者：
Wortel, Ruud
Incrocci, Luca
机构：
来源：
JOURNAL OF UROLOGY | 2016年 / 195卷 / 04期
关键词：
D O I：
10.1016/j.juro.2016.02.321
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP47-02
引用
收藏
页码：E626 / E627
页数：2
相关论文
共 50 条
  • [1] Sexual Function After Hypofractionated Versus Conventionally Fractionated Radiotherapy for Prostate Cancer: Results From the Randomized Phase III HYPRO Trial
    Wortel, Ruud C.
    Pos, Floris J.
    Heemsbergen, Wilma D.
    Incrocci, Luca
    Journal of Sexual Medicine, 2016, 13 (11): : 1695 - 1703
  • [2] HYPOFRACTIONATED VERSUS CONVENTIONALLY FRACTIONATED RADIOTHERAPY FOR PROSTATE CANCER: 5-YEAR ONCOLOGIC OUTCOMES OF THE DUTCH RANDOMIZED PHASE 3 HYPRO TRIAL
    Wortel, Ruud
    Incrocci, Luca
    Aluwini, Shafak
    Schimmel, Erik
    Krol, Stijn
    van der Toorn, Peter-Paul
    de Jager, Hanja
    Dirkx, Maarten
    Ghidey, Wendim
    Heijmen, Ben
    Pos, Floris
    JOURNAL OF UROLOGY, 2016, 195 (04): : E142 - E143
  • [3] HYPOFRACTIONATED VERSUS CONVENTIONALLY FRACTIONATED RADIOTHERAPY FOR PROSTATE CARCINOMA: FINAL RESULTS OF PHASE III RANDOMIZED TRIAL
    Yeoh, Eric E.
    Botten, Rochelle J.
    Butters, Julie
    Di Matteo, Addolorata C.
    Holloway, Richard H.
    Fowler, Jack
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1271 - 1278
  • [4] Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
    Aluwini, Shafak
    Pos, Floris
    Schimmel, Erik
    Krol, Stijn
    van der Toorn, Peter Paul
    de Jager, Hanja
    Alemayehu, Wendimagegn Ghidey
    Heemsbergen, Wilma
    Heijmen, Ben
    Incrocci, Luca
    LANCET ONCOLOGY, 2016, 17 (04): : 464 - 474
  • [5] Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
    Aluwini, Shafak
    Pos, Floris
    Schimmel, Erik
    van Lin, Emile
    Krol, Stijn
    van der Toorn, Peter Paul
    de Jager, Hanja
    Dirkx, Maarten
    Alemayehu, Wendimagegn Ghidey
    Heijmen, Ben
    Incrocci, Luca
    LANCET ONCOLOGY, 2015, 16 (03): : 274 - 283
  • [6] Hypofractionated Versus Conventionally Fractionated Radiation Therapy for Prostate Cancer: Five-Year Oncologic Outcomes of the Dutch Randomized Phase 3 HYPRO Trial
    Incrocci, L.
    Wortel, R. C.
    Aluwini, S.
    Schimmel, E.
    Krol, A. D. G.
    Van der Toorn, P. P.
    de Jager, H.
    Dirkx, M.
    Alemayehu, W. Ghidey
    Heijmen, B.
    Pos, F. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 1 - 2
  • [7] Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
    Incrocci, Luca
    Wortel, Ruud C.
    Alemayehu, Wendimagegn Ghidey
    Aluwini, Shafak
    Schimmel, Erik
    Krol, Stijn
    van der Toorn, Peter-Paul
    de Jager, Hanja
    Heemsbergen, Wilma
    Heijmen, Ben
    Pos, Floris
    LANCET ONCOLOGY, 2016, 17 (08): : 1061 - 1069
  • [8] Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
    Heemsbergen, Wilma D.
    Incrocci, Luca
    Pos, Floris J.
    Heijmen, Ben J. M.
    Witte, Marnix G.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [9] Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial (vol 16, pg 274, 2015)
    Aluwini, S.
    Pos, F.
    Schimmel, E.
    LANCET ONCOLOGY, 2015, 16 (03): : E105 - E105
  • [10] Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial
    Yeoh, Eric E.
    Holloway, Richard H.
    Fraser, Robert J.
    Botten, Rochelle J.
    Di Matteo, Addolorata C.
    Butters, Julie
    Weerasinghe, Sujeeva
    Abeysinghe, Prasad
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (04): : 1072 - 1083
12345